Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-04-01FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
FDA approved a supplemental application for TYSABRI (Natalizumab) filed by Biogen Inc. The action represents an approved regulatory update t…
-
FDA approval · 2011-03-23FDA Approved: AZATHIOPRINE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for azathioprine from Rising Pharma Holdings, Inc., under an existing ANDA. This action confirms the…
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study [NA]
An exploratory pilot trial evaluating pravastatin therapy in patients with active Crohn's disease is described, with no study results or sta…
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Bronchial Hyperreactivity in Children With Crohn Disease
This update reports the completion of a clinical trial studying bronchial hyperreactivity in pediatric patients with Crohn's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-01-20FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
FDA approved a supplemental application submitted by Sunrise Pharmaceutical, Inc. under ANDA040349 to market a generic form of sulfasalazine…
-
CLINICAL_TRIALS research · 2011-01-11Clinical Trial Update: The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy
This clinical trial update discusses the potential utility of fecal calprotectin and lactoferrin as biomarkers in Crohn's disease patients u…
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease [Phase 3]
Phase 3 trial evaluating certolizumab pegol for induction of remission in Crohn's disease completed with results posted.
-
FDA approval · 2010-12-28FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved Janssen Biotech, Inc.'s supplemental application for infliximab. The approval updates the product's labeling and indications as…
-
CLINICAL_TRIALS trial_result · 2010-12-16Clinical Trial Update: Drug-Disease Interaction in Crohn's Disease [Phase 1]
Phase 1 clinical trial evaluating a drug-disease interaction in Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2010-12-16Clinical Trial Update: Fecal Calprotectin as a Marker for Macroscopic Recurrence of Crohn's Disease After Intestinal Resection
This clinical trial update evaluates whether fecal calprotectin can indicate macroscopic recurrence of Crohn's disease after intestinal rese…
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease [Phase 3]
Phase 3 trial update on certolizumab for Crohn's disease evaluating corticosteroid-sparing effect; terminated with results posted in 2010.
-
CLINICAL_TRIALS research · 2010-11-19Clinical Trial Update: Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease
A clinical trial update about using low-dose CT with iterative reconstruction in patients with inflammatory bowel disease, including Crohn's…
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients [Phase 4]
A Phase 4 trial evaluated the effect of vitamin K supplementation on bone health in adults with Crohn's disease. The University College Cork…
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease [Phase 2]
A Phase II trial evaluating topical tacrolimus 0.1% ointment for cutaneous Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-02Clinical Trial Update: Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose [Phase 1]
Phase 1 study update from Zealand Pharma evaluating a candidate drug in healthy volunteers (single ascending dose) and Crohn's disease patie…
-
CLINICAL_TRIALS research · 2010-11-01Clinical Trial Update: Green Tea in Crohn's Disease [NA]
An update on a clinical trial evaluating green tea for Crohn's disease; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease [Phase 4]
Phase 4 clinical trial evaluating risedronate for low bone mineral density in Crohn's disease has completed, sponsored by the University of …
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: A Study of Abatacept in Patients With Active Crohn's Disease [Phase 3]
A Phase 3 trial evaluating abatacept for active Crohn's disease was terminated, with results posted in 2010.
-
FDA approval · 2010-07-29FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
FDA approval · 2010-07-29FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc., resulting in an approved amendment to it…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Stop Infliximab in Patients With Crohn's Disease [Phase 3]
A Phase 3 trial evaluating stopping infliximab therapy in Crohn's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Curcumin in Pediatric Inflammatory Bowel Disease [Phase 1]
Phase 1 clinical trial evaluating curcumin in pediatric inflammatory bowel disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy [NA]
This clinical trial update reports on adalimumab's ability to induce small bowel mucosal healing in Crohn's disease patients, assessed using…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease [Phase 2, Phase 3]
This document reports the results of a Phase 2/3 trial evaluating adalimumab for maintenance of clinical remission in Japanese subjects with…